Letters to Healthcare Providers
|
| |
| Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): updated safety and educational materials to support patient discussion on reproductive risks (Letter to Healthcare Professionals) |
| |
| |
| |
|
| Related Information: | | European Union: PRAC assessing new data on potential risk of neurodevelopmental ... Posted 2025-07-12 | | The United Kingdom: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epil... Posted 2025-06-11 | | Australia: Potential risk of neurodevelopmental disorders in children born to me... Posted 2025-03-07 | | The United Kingdom: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epil... Posted 2025-02-14 | | The United Kingdom: Valproate use in men: as a precaution, men and their partner... Posted 2024-09-06 | | European Union: Precautionary measures to address potential risk of neurodevelop... Posted 2024-01-27 | | Singapore: Epilim® (valproate): Updates and new measures relating to the risk of... Posted 2024-01-24 | | European Union: Potential risk of neurodevelopmental disorders in children born ... Posted 2024-01-13 | | The United Kingdom: MHRA instructs health organisations to prepare now for new m... Posted 2023-11-30 | | The United Kingdom: Valproate: re-analysis of study on risks in children of men ... Posted 2023-08-31 | | European Union: EMA review of data on paternal exposure to valproate Posted 2023-08-17 | | The United Kingdom: Safety of valproate – new study on risks in children of men ... Posted 2023-08-17 | | Singapore: Epilim® (valproate): Risk of neurodevelopmental disorders including a... Posted 2023-03-22 | | Epilim® (valproate) - Risk of neurodevelopmental disorders including autism spec... Posted 2023-03-22 | | The United Kingdom: Valproate: reminder of current Pregnancy Prevention Programm... Posted 2022-12-13 | | Valproate: MHRA's reminder of current Pregnancy Prevention Programme requirement... Posted 2022-12-13 | | 台灣：公告修訂含valproate類成分藥品用於婦女的使用原則 (Chinese only) Posted 2019-06-24 | | Singapore: Epilim® (valproate) – New restrictions on use Posted 2018-10-30 | | United Kingdom : Valproate Pregnancy Prevention Programme: actions required now ... Posted 2018-09-26 | | Singapore: Valproate-containing medicines and risk of teratogenicity – An update Posted 2018-09-19 | | The United Kingdom: Valproate medicines: contraindicated in women and girls of c... Posted 2018-04-25 | | European Union and the United Kingdom: Information about the risks of taking val... Posted 2018-03-24 | | Singapore: Epilim® (valproate) - Risk of congenital malformations and serious de... Posted 2018-03-16 | | PRAC recommends new measures to avoid valproate exposure in pregnancy. New restr... Posted 2018-02-12 | | European Union: PRAC recommends new measures to avoid valproate exposure in preg... Posted 2018-02-10 | | The United Kingdom: Valproate and developmental disorders: new alert asking for ... Posted 2017-04-25 | | European Union: New review of valproate use in pregnancy and women of childbeari... Posted 2017-03-13 | | European Union: Update on the ongoing review of valproate and related substances Posted 2014-07-14 | |
